Larimar Therapeutics Shares Are Trading Higher After Leerink Partners Initiated Coverage on the Stock With an Outperform Rating and $25 Price Target
Larimar Therapeutics的股價走高,此前Leerink Partners以跑贏大盤的評級和25美元的目標股價開始對該股進行報道
Larimar Therapeutics Shares Are Trading Higher After Leerink Partners Initiated Coverage on the Stock With an Outperform Rating and $25 Price Target
Larimar Therapeutics的股價走高,此前Leerink Partners以跑贏大盤的評級和25美元的目標股價開始對該股進行報道
使用瀏覽器的分享功能,分享給你的好友吧